News

Lexeo Therapeutics, Inc.’s LXEO share price has dipped by 6.54%, which has investors questioning if this is right time to buy ...
Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...
Although only tested in rats thus far, the polymer-based treatment could repair tissue that are impacted in a variety of ...
One of the Trump administration’s top health officials said Friday that the federal government is working to expand access to ...
U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. made a stop in downtown Charleston Friday morning.
Thirty-five states have agreed to participate in a federal pilot program aimed at helping Medicaid patients access costly ...
To satisfy their fiduciary obligations, self-funded plan sponsors must take a proactive, informed approach to health plan ...
Robert F. Kennedy Jr. announces sickle-cell treatment program in Charleston while assuring SC Sen. Tim Scott that federal ...
Robert F. Kennedy Jr. made a landmark announcement in Charleston while also assuring SC Sen. Tim Scott that a federal ...
Sickle cell has been overlooked for far too long. Fortunately, there are new breakthroughs in sickle cell treatment that you ...
The cell and gene therapy company is cutting 47 employees and its entire lupus program to focus resources on two CAR Ts. The ...
Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...